Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.

Jacobson, J M; Spritzler, J; Fox, L; Fahey, J L; Jackson, J B; Chernoff, M; Wohl, D A; Wu, A W; Hooton, T M; Sha, B E; Shikuma, C M; MacPhail, L A; Simpson, D M; Trapnell, C B; Basgoz, N

Jacobson, J M; Spritzler, J; Fox, L; Fahey, J L; Jackson, J B; Chernoff, M; Wohl, D A; Wu, A W; Hooton, T M; Sha, B E; Shikuma, C M; MacPhail, L A; Simpson, D M; Trapnell, C B; Basgoz, N.

Affiliation

Jacobson JM; Mount Sinai Medical Center, New York, NY 10029, USA. jeffrey_jacobson@smtplink.mssm.edu

J Infect Dis ; 180(1): 61-7, 1999 Jul.

Article in En | MEDLINE | ID: mdl-10353862

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Ulcer / HIV Infections / Esophageal Diseases Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Infect Dis Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links